MANSFIELD, Mass., April 10 /PRNewswire/ -- NDO Surgical, Inc. announced that Bernard Haffey joins the company as President and CEO. He will also serve on the board of directors. Formerly Executive Vice President and Chief Commercial Officer at IntraLase Corp., Haffey brings valuable expertise guiding a number of early-stage medical devices and therapies to commercial viability and global adoption.
Haffey will lead NDO Surgical’s research and commercial development efforts for the Plicator, the Company’s minimally invasive treatment for GERD. He will focus on continuing to improve the reimbursement landscape while raising the capital necessary to elevate the commercial adoption rate of the Plicator procedure. “Bernie has a proven track record of successfully launching emerging medical technologies,” said Dr. Laufer, chairman of NDO Surgical. “We are confident he has the experience, energy and vision to help NDO Surgical reach our ultimate goal -- providing GERD sufferers worldwide with safe and effective treatment of breakthrough symptoms.”
Over the last ten years, Haffey held executive roles at several innovative medical technology companies, and successfully helped bring two of those companies to acquisition. Under Haffey’s leadership, IntraLase launched its laser vision technology globally, grew company revenues to over $130 million and achieved significant operating profitability. IntraLase was acquired by Advanced Medical Optics (AMO) on April 2, 2007. Haffey will continue to support the integration of IntraLase into AMO as a consultant through June 2007.
Prior to IntraLase, Haffey served as CEO at NeuroVision, Inc., as well as Executive Vice President and Chief Commercial Officer at Summit Autonomous, Inc. Summit Autonomous was acquired by Alcon Laboratories in 2000. Mr. Haffey’s record of success within the medical device sector also includes having served at Mentor Ophthalmics, Inc. as Vice President of Sales and Marketing, and at Hewlett-Packard Medical Products Group in marketing. A graduate of Colgate University, Haffey also holds an MBA from Cornell University, Johnson Graduate School of Management.
“This is a great time to join NDO Surgical,” said Haffey. “Recently published data continues to demonstrate the efficacy and durability of Plicator technology for the treatment of GERD. I look forward to continuing to develop the clinical proof necessary to support our best-in-class technology while building a world class team focused on customer satisfaction.”
About NDO Surgical Based in Mansfield, Mass., NDO Surgical is a privately held medical technology company dedicated to the development of innovative endoscopic technologies for gastrointestinal diseases. Investors include Versant Ventures, Polaris Ventures, and Menlo Ventures. Additional information is available at the Company’s website at www.ndosurgical.com.
About Versant Ventures Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in 1999, consists of a seasoned team of eleven managing directors with more than 105 years of venture capital investing experience and more than 145 years of operating experience. Versant Ventures currently manages over $1 billion in committed capital having raised its third fund in November 2005, and is currently managing over 70 companies in its portfolio. For additional information, please visit www.versantventures.com.
About Polaris Ventures Established in 1996, with offices in Waltham and Seattle, Polaris has over $3 billion under management. Polaris Venture Partners have helped build numerous market leading companies, including Accordant Health Services, Advanced Inhalation Research, Akamai Technologies, Allaire, Alnylam Pharmaceuticals, American Superconductor, Aspect Medical Systems, Avici Systems, Centra Software, Classifieds2000, deCODE genetics, Exchange.com, Matrics, Microbia, Momenta Pharmaceuticals, Paradigm Genetics, Powersoft, PSCI, SolidWorks and TransForm Pharmaceuticals. More information about Polaris Venture Partners is available at www.polarisventures.com.
About Menlo Ventures Menlo Ventures provides long-term capital and management support to early- stage and emerging-growth companies from its latest $1.2 billion venture capital fund. The firm is one of Silicon Valley’s oldest venture capital partnerships, and has organized and managed ten venture funds since inception in 1976. With over $3.9 billion under management, and a team with over one hundred years of collective experience in technology, marketing, sales and general management, Menlo Ventures has the expertise and resources to support the most ambitious of growing companies. For additional information, please visit www.menloventures.com.
Source: NDO Surgical, Inc.
